Search by Drug Name or NDC
NDC 58602-0804-83 Pseudoephedrine HCl 120 mg/1 Details
Pseudoephedrine HCl 120 mg/1
Pseudoephedrine HCl is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Aurohealth LLC. The primary component is PSEUDOEPHEDRINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.
Related Packages: 58602-0804-83Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Pseudoephedrine
Product Information
NDC | 58602-0804 |
---|---|
Product ID | 58602-804_5f73d533-1e3b-4e36-8bea-6076b9d0a9b5 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Pseudoephedrine HCl |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Pseudoephedrine HCl |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, EXTENDED RELEASE |
Route | ORAL |
Active Ingredient Strength | 120 |
Active Ingredient Units | mg/1 |
Substance Name | PSEUDOEPHEDRINE HYDROCHLORIDE |
Labeler Name | Aurohealth LLC |
Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA209008 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 58602-0804-83 (58602080483)
NDC Package Code | 58602-804-83 |
---|---|
Billing NDC | 58602080483 |
Package | 1 BLISTER PACK in 1 CARTON (58602-804-83) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Marketing Start Date | 2017-06-09 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 1056d9da-8a3f-4b7a-878e-7f8d45d298cd Details
Uses
Do not use
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
Stop use and ask a doctor if
Keep out of reach of children.
Directions
Other information
Inactive ingredients
Questions or comments?
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 120 mg, Blister Carton 20 (2 X 10) Extended-Release Tablets
INGREDIENTS AND APPEARANCE
PSEUDOEPHEDRINE HCL
pseudoephedrine hcl tablet, extended release |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
Labeler - Aurohealth LLC (078728447) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Aurobindo Pharma Limited | 650381903 | ANALYSIS(58602-804) , MANUFACTURE(58602-804) |